1. Home
  2. ANIX vs FEIM Comparison

ANIX vs FEIM Comparison

Compare ANIX & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

SELL

Current Price

$2.67

Market Cap

114.0M

Sector

Health Care

ML Signal

SELL

Logo Frequency Electronics Inc.

FEIM

Frequency Electronics Inc.

HOLD

Current Price

$65.00

Market Cap

722.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
FEIM
Founded
1982
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
722.9M
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
ANIX
FEIM
Price
$2.67
$65.00
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$9.75
★ $95.50
AVG Volume (30 Days)
278.6K
★ 285.9K
Earning Date
09-09-2026
09-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 12.82
N/A
EPS
N/A
★ 0.41
Revenue
$210,000.00
★ $63,227,000.00
Revenue This Year
N/A
$30.80
Revenue Next Year
N/A
$26.18
P/E Ratio
★ N/A
$170.68
Revenue Growth
★ N/A
N/A
52 Week Low
$2.32
$26.05
52 Week High
$5.46
$89.76

Technical Indicators

Market Signals
Indicator
ANIX
FEIM
Relative Strength Index (RSI) 40.03 32.94
Support Level $2.62 $55.99
Resistance Level $3.09 $79.36
Average True Range (ATR) 0.15 3.85
MACD -0.01 -2.44
Stochastic Oscillator 8.33 2.42

Price Performance

Historical Comparison
ANIX
FEIM

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is a world leader in precision time and frequency generation technology, which is incorporated into commercial and U.S. Government satellites, Command, Control, Communication, Computer, Intelligence, Surveillance and Reconnaissance, and Electronic Warfare systems. Its technology is used for a wide range of space and non-space applications. The company has two segments FEI-NY, and FEI-Zyfer. Majority of revenue come from FEI-NY which provides precision time, frequency generation and synchronization products and subsystems that are found on-board satellites, in ground-based communication systems and imbedded in mobile platforms operated by the U.S. military.

Share on Social Networks: